Kerry Salandria, PhDAssociate Director, Analytical Operations at Moderna
Kerry Salandria is currently an Associate Director leading Analytical Technical Operations at Moderna. The team is responsible for providing rapid and reliable analytical data to Technical Development and Manufacturing organizations. Robust, high-throughput methodologies are a critical component to the team’s success – enabling automation and minimizing sources of error are key drivers for the organization. Kerry holds a PhD in Chemistry from Boston College, where she studied the impact of minor groove modifications on DNA structure, and spent the early years of her career at Idenix Pharmaceuticals and Qiagen supporting the synthesis and application of modified nucleotides in pharmaceutical and diagnostics.